MedPath

Necon

Necon (Norethindrone and Ethinyl Estradiol Tablets, USP, 0.5 mg/0.035 mg)

Approved
Approval ID

1ca12bf6-9583-4578-8411-51ad02a405ec

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 23, 2024

Manufacturers
FDA

Dr. Reddy's Laboratories Inc.

DUNS: 802315887

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

norethindrone and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code75907-085
Application NumberANDA091204
Product Classification
M
Marketing Category
C73584
G
Generic Name
norethindrone and ethinyl estradiol
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 23, 2024
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Necon - FDA Drug Approval Details